Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Imayavaramban Lakshmanan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1733-2223; OpenAlex author ID A5015031419. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 3 papers · 2016: 3 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXCL5/CXCR2 signaling axis. Co-author DOI 10.1016/j.canlet.2026.218269↗
  2. MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1073820↗
  3. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-022-02493-6↗
  4. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion. First author DOI 10.1158/1541-7786.mcr-21-0888↗
  5. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Co-author DOI 10.1053/j.gastro.2018.05.041↗
  6. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.molonc.2015.10.005↗
  7. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Co-author DOI 10.18632/genesandcancer.104↗
  8. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.6580↗
  9. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer. Co-author DOI 10.18632/oncotarget.3286↗
  10. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3308↗
  11. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3912↗
  12. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-2174↗
  13. Pathobiological implications of MUC16 expression in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0026839↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 13 shared papers, 2011–2026 · strength 1.13
  2. Moorthy Palanimuthu Ponnusamy · 10 shared papers, 2011–2023 · strength 0.77
  3. Satyanarayana Rachagani · 10 shared papers, 2011–2022 · strength 0.56
  4. Apar Kishor Ganti · 4 shared papers, 2015–2026 · strength 0.48
  5. Rama Krishna Nimmakayala · 4 shared papers, 2018–2023 · strength 0.48
  6. Maneesh Jain · 4 shared papers, 2015–2023 · strength 0.46
  7. Subodh M. Lele · 5 shared papers, 2011–2026 · strength 0.45
  8. Lynette M. Smith · 7 shared papers, 2014–2022 · strength 0.44
  9. Namita Bhyravbhatla · 3 shared papers, 2022–2023 · strength 0.41
  10. Sanjib Chaudhary · 2 shared papers, 2022–2026 · strength 0.38
  11. Sakthivel Muniyan · 4 shared papers, 2016–2022 · strength 0.35
  12. Muzafar Ahmad Macha · 2 shared papers, 2016–2026 · strength 0.33
  13. Parthasarathy Seshacharyulu · 5 shared papers, 2015–2022 · strength 0.33
  14. Sushil Kumar K · 3 shared papers, 2011–2023 · strength 0.31
  15. Pranita Atri · 3 shared papers, 2018–2022 · strength 0.30
  16. Sanchita Rauth · 3 shared papers, 2018–2022 · strength 0.30
  17. Dhanya Haridas · 5 shared papers, 2011–2022 · strength 0.29
  18. Ramakanth Chirravuri‐Venkata · 2 shared papers, 2022–2023 · strength 0.28
  19. Kavita B. Mallya · 3 shared papers, 2014–2022 · strength 0.28
  20. Koelina Ganguly · 1 shared paper, 2026 · strength 0.27
  21. Ramesh Pothuraju · 1 shared paper, 2026 · strength 0.27
  22. Jesse L. Cox · 1 shared paper, 2026 · strength 0.27
  23. Shailendra Kumar Gautam · 2 shared papers, 2022 · strength 0.24
  24. Ashu Shah · 2 shared papers, 2022 · strength 0.24
  25. Saravanakumar Marimuthu · 2 shared papers, 2022 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.